1. Home
  2. MTW vs NMRA Comparison

MTW vs NMRA Comparison

Compare MTW & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTW
  • NMRA
  • Stock Information
  • Founded
  • MTW 1902
  • NMRA 2019
  • Country
  • MTW United States
  • NMRA United States
  • Employees
  • MTW N/A
  • NMRA N/A
  • Industry
  • MTW Construction/Ag Equipment/Trucks
  • NMRA
  • Sector
  • MTW Industrials
  • NMRA
  • Exchange
  • MTW Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • MTW 350.6M
  • NMRA 287.6M
  • IPO Year
  • MTW N/A
  • NMRA 2023
  • Fundamental
  • Price
  • MTW $8.58
  • NMRA $1.01
  • Analyst Decision
  • MTW Sell
  • NMRA Buy
  • Analyst Count
  • MTW 5
  • NMRA 8
  • Target Price
  • MTW $11.76
  • NMRA $10.14
  • AVG Volume (30 Days)
  • MTW 205.4K
  • NMRA 1.2M
  • Earning Date
  • MTW 05-06-2025
  • NMRA 03-03-2025
  • Dividend Yield
  • MTW N/A
  • NMRA N/A
  • EPS Growth
  • MTW 43.12
  • NMRA N/A
  • EPS
  • MTW 1.56
  • NMRA N/A
  • Revenue
  • MTW $2,178,000,000.00
  • NMRA N/A
  • Revenue This Year
  • MTW $2.02
  • NMRA N/A
  • Revenue Next Year
  • MTW $3.92
  • NMRA N/A
  • P/E Ratio
  • MTW $5.70
  • NMRA N/A
  • Revenue Growth
  • MTW N/A
  • NMRA N/A
  • 52 Week Low
  • MTW $8.30
  • NMRA $0.95
  • 52 Week High
  • MTW $14.32
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • MTW 32.38
  • NMRA 26.42
  • Support Level
  • MTW $9.21
  • NMRA $1.12
  • Resistance Level
  • MTW $9.79
  • NMRA $1.23
  • Average True Range (ATR)
  • MTW 0.32
  • NMRA 0.10
  • MACD
  • MTW -0.08
  • NMRA 0.04
  • Stochastic Oscillator
  • MTW 5.97
  • NMRA 2.18

About MTW Manitowoc Company Inc. (The)

Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: